molim Inc. | Pioneering Molecular Imaging for Translational Drug Development

molim Inc. is South Korea’s first and only private CRO fully specialized in molecular imaging for both preclinical and clinical-stage drug development.

We empower pharmaceutical and biotech companies by providing cutting-edge radiolabeling and molecular imaging services that visualize and quantify the pharmacokinetics (PK), biodistribution, and mechanism of action (MoA) of biologics — including antibodies, extracellular vesicles (EVs), gene & cell therapies, and novel modalities.

Why molim?
🛡 The Only Private Molecular Imaging CRO in Korea
🌱 First in Korea to offer exploratory Phase 0 clinical imaging trials
⚡ Fastest time-to-data with streamlined imaging and analysis pipelines
📚 Largest molecular imaging data library in the country
🏆 Proven global-standard imaging quality and regulatory-compliant expertise

Our Services
Radiolabeling (Antibodies, EVs, small molecules, mRNA/LNP, etc.)

In vivo imaging (PET/CT, SPECT, optical)

Preclinical biodistribution & PK studies

Clinical molecular imaging (Phase 0/I)

Data analysis & regulatory documentation

🌐 Our Mission
To accelerate the translation of cutting-edge biotherapeutics from bench to bedside, by delivering quantitative, visual, and regulatory-grade evidence through molecular imaging.

molim Inc.

Org chart

Teams

Offices